Filter
535
Filtered Results: 535
Text search:
Clinical
characterization
Featured
Recommendations
57
New Publications
88
Language
Document type
No document type
182
Guidelines
129
Studies & Reports
123
Manuals
40
Fact sheets
25
Strategic & Response Plan
24
Situation Updates
8
Training Material
3
Resource Platforms
1
Countries / Regions
Global
23
India
21
Latin America and the Carribbean
20
Africa
17
Brazil
12
Kenya
9
Nigeria
9
Western and Central Europe
9
South Africa
8
Russia
8
Colombia
7
Middle East and North Africa
7
Germany
6
West and Central Africa
6
Uganda
6
Namibia
6
Liberia
6
Sierra Leone
5
Venezuela
5
East and Southern Africa
5
Zambia
5
Western Pacific Region
4
Eastern Europe and Central Asia
4
Ghana
3
Rwanda
3
Syria
3
Zimbabwe
3
Philippines
3
Mozambique
3
USA
3
Tanzania
3
Angola
3
Tajikistan
2
Chile
2
Cameroon
2
Burkina Faso
2
Peru
2
Malawi
2
Guinea
2
Congo, Democratic Republic of
2
South–East Asia Region
2
France
2
Bolivia
2
Argentina
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Pakistan
2
Nepal
1
Ukraine
1
Lesotho
1
Turkey
1
Benin
1
Senegal
1
Afghanistan
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Jordan
1
Portugal
1
Southern Africa
1
Vietnam
1
Sudan
1
Ethiopia
1
South Sudan
1
Indonesia
1
Ecuador
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
146
Clinical Guidelines
60
Public Health
27
Pharmacy & Technologies
20
Key Resources
11
Women & Child Health
9
Capacity Building
4
Toolboxes
COVID-19
112
Rapid Response
58
AMR
52
NTDs
38
HIV
20
TB
19
Mental Health
18
Pharmacy
18
Ebola
16
Planetary Health
15
Zika
12
NCDs
9
Cholera
6
Disability
5
Caregiver
5
Specific Hazards
4
Refugee
4
Natural Hazards
3
Conflict
3
Health Financing Toolbox
2
Polio
2
Global Health Education
2
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Severe asthma is associated with high morbidity, mortality, and health care utilization, but its burden in Africa is unknown. This article wants to determine the burden (prevalence,
mortality, and activity and work impairment) of severe asthma in 3 countries in East Africa: Uganda, Kenya, and Ethio...
EClinicalMedicine 1 (2018) 21–27
https://doi.org/10.1016/j.eclinm.2018.06.005
2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
EClinicalMedicine: journal homepage: https://www.jo...
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
Clinical Microbiology and Infection Volume 21, Issue 5, May 2015, Pages 433-443;
The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries, but remain major causes of ill-health and mortality across Africa, Asia, and Latin America. This neglect is, in part, a conse...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
The Transatlantic Task Force on Antimicrobial Resistance (TATFAR) fosters cooperation between the European Union (EU) andthe United States (US) on the issue of antimicrobial resistance. The first TATFAR recommendation refers to appropriate use of antimicrobials in human medicine through hospital Ant...
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
Hendra virus (HeV) continues to pose a serious public health concern as spillover events occur sporadically. Terminally ill horses can exhibit a range of clinical signs including frothy nasal discharge, ataxia or forebrain signs. Early signs, if detected, can include depression, inappetence, colic o...
This Manual covers all important aspects of echinococcosis, including parasite biology and life-cycles, geographic distribution and prevalence, epidemiology, clinical presentation in humans and animals, diagnosis and treatment, as well as control and prevention using newly developed tools and method...
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also inter...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular ...
Prepared as an outcome of ICMR Subcommittee on Tongue Cancer | This Consensus Document on Management of Tongue Cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interw...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
